Barbara von Frankenberg
Public Communications Contact en SUSS Microtec, Inc. .
Origen de la red de primer grado Barbara von Frankenberg.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
SUSS Microtec, Inc.
 SUSS Microtec, Inc. SemiconductorsElectronic Technology SUSS Microtec, Inc. supplies precision technology products. It provides innovative solutions for markets including advanced packaging, MEMS, Nanotechnology, compound semiconductor, silicon-on-insulator and 3D Interconnect. The company also manufactures a complete line of photoresist and dielectric coat/bake/develop systems, microlithography exposure systems, wafer and device bonders, probers, photomasks, cleaners, and etchers. It was founded by Karl Süss in 1949 and is headquartered in Waterbury Center, VT.
6
| Subsidiary | Semiconductors | 6 |
| Public Company | Medical Specialties | 5 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Barbara von Frankenberg a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Film House Germany AG
 Film House Germany AG Movies/EntertainmentConsumer Services Film House Germany AG is a motion picture and film company based in Germany. The private company was founded by Christian Angermayer and the CEO is Marc Hansell. | Movies/Entertainment | Director/Board Member Director of Finance/CFO Director/Board Member | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder Founder | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Analyst Chairman | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Founder | |
| COREO AG | Financial Conglomerates | Chairman Chief Executive Officer | |
| JDC GROUP AG | Investment Managers | Director/Board Member Director/Board Member | |
Heliad Management GmbH
 Heliad Management GmbH Investment ManagersFinance Heliad Management GmbH (Heliad) is the wholly-owned private equity subsidiary of FinLab AG (FR: A7A). Formerly known as Sigma Capital Management GmbH, the firm was established in 2000 as VertureCap Consultants GmbH. It was renamed to Sigma Capital in 2006 and subsequently became Altira Heliad Management GmbH. Since 2016 the firm is known as Heliad Management GmbH. The firm is headquartered in Frankfurt, Germany. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| University of Regensburg | College/University | Undergraduate Degree | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| H2 CORE AG | Electrical Products | Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal | |
MagForce USA Holding GmbH
 MagForce USA Holding GmbH Miscellaneous Commercial ServicesCommercial Services Part of MagForce AG, MagForce USA Holding GmbH provides business and economic services. The company is based in Berlin, Germany. The German company was founded in 2018. Christian von Volkmann has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Julius-Maximilians-Universität Würzburg | College/University | Undergraduate Degree | |
ZEAL Network SE (Germany)
 ZEAL Network SE (Germany) Financial ConglomeratesFinance Part of ZEAL Network SE, ZEAL Network SE (Germany) is a leading German online broker for state and other permitted lottery products. The company is based in Hamburg, Germany. The German company promotes a culture of innovation and encourages its employees to challenge the status quo. ZEAL values diversity and teamwork while allowing individuality to flourish. ZEAL's aim is to innovate and drive change in the lottery sector while remaining the market leader. Founded in 1999, the CEO is Helmut Becker. | Financial Conglomerates | Chairman | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Arenberg Consult GmbH | Chairman | ||
| Max Planck Institute of Neurobiology | College/University | Doctorate Degree | |
| IMMATICS N.V. | Biotechnology | Corporate Officer/Principal | |
| COMMERZBANK AG | Regional Banks | Chief Operating Officer | |
| Universität zu Köln | College/University | Undergraduate Degree | |
| CONERGY AG | Semiconductors | Director/Board Member | |
Consortia Vermögensverwaltung AG
 Consortia Vermögensverwaltung AG Investment ManagersFinance Consortia Vermögensverwaltung AG (Consortia) is an independent German asset management firm which was formerly known as VCH Vermögensverwaltung AG. Established in 1991, the firm changed their name to Consortia Vermögensverwaltung AG in 2017. Consortia is based in Cologne and provides institutional clients and private investors with mutual funds, closed-end funds and hedge funds; however the management of most their funds is outsourced to third-party managers. | Investment Managers | Director/Board Member | |
| University of Münster | College/University | Graduate Degree | |
| Martin-Luther-Universität Halle-Wittenberg | College/University | Graduate Degree | |
| InTiCa Systems SE | Director of Finance/CFO | ||
| University of St. Gallen | College/University | Undergraduate Degree | |
Principal Real Estate Spezialfondsgesellschaft mbH
 Principal Real Estate Spezialfondsgesellschaft mbH Real Estate DevelopmentFinance Principal Real Estate Spezialfondsgesellschaft mbH (PRES) is a real estate management firm headquartered in Frankfurt, Germany. The firm was founded in 2008 and is a subsidiary of Great Britain-based Principal Real Estate Ltd., which is owned by Principal Financial Group, Inc. (NASDAQ: PFG) in the US. PRES manages or sub advises real estate assets. | Real Estate Development | Director/Board Member | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
Commerzbank Zrt
 Commerzbank Zrt Major BanksFinance Commerzbank Zrt operates as a commercial bank. Its products and services include Private Clients, Business Clients, and Corporate Clients. The company was founded on January 11, 1993 and was headquartered in Budapest, Hungary. | Major Banks | Director/Board Member | |
Arenberg Schleiden GmbH
 Arenberg Schleiden GmbH Real Estate DevelopmentFinance Arenberg Schleiden GmbH provides real estate management services. The company is based in Dusseldorf, Germany and has subsidiaries in Germany. The German company was founded in 1928. The CEO is Martin Rothfuchs. | Real Estate Development | Chairman | |
Arenberg - Recklinghausen GmbH
 Arenberg - Recklinghausen GmbH Real Estate DevelopmentFinance Arenberg - Recklinghausen GmbH provides real estate services. The private company is based in Dusseldorf, Germany. The German company was founded in 1936. Martin Rothfuchs has been the CEO of the company since 2017. | Real Estate Development | Chairman | |
Doertenbach & Co. GmbH
 Doertenbach & Co. GmbH Investment Banks/BrokersFinance Doertenbach & Co. GmbH operates as an investment banking firm. It focuses on structuring and executing mergers & acquisitions as well as financing transactions. The company is headquartered in Frankfurt am Main, Germany. | Investment Banks/Brokers | Corporate Officer/Principal | |
| EISEN- UND HÜTTENWERKE AG | Financial Conglomerates | Director/Board Member | |
| Grundkredit- und Bodenverwaltung GmbH | Chairman | ||
| ZEAL NETWORK SE | Movies/Entertainment | Chairman | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
| CLINICAL LASERTHERMIA SYSTEMS AB | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
| HALLMANN Entertainment Co. GmbH | Corporate Officer/Principal | ||
The British United Provident Association Ltd.
 The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | Life/Health Insurance | Sales & Marketing | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ohmeda Pharmaceuticals | Corporate Officer/Principal | ||
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree |
Estadísticas
Internacional
| Alemania | 36 |
| Estados Unidos | 7 |
| Suiza | 3 |
| Suecia | 3 |
| Países Bajos | 2 |
Sectorial
| Finance | 15 |
| Health Technology | 14 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 71 |
| Chairman | 33 |
| Corporate Officer/Principal | 30 |
| Chief Executive Officer | 20 |
| Director of Finance/CFO | 13 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Stefan Schütze | 31 |
| Hubert Birner | 27 |
| Berndt A. E. Modig | 23 |
| Theresa Heggie | 16 |
| Norbert Neef | 14 |
| Carl Ulrich Andreas de Maizière | 14 |
| Jochen Knolle | 11 |
| Rainer Kramer | 10 |
| Klemens Hallmann | 9 |
| Stephan Schulak | 6 |
| Christian von Volkmann | 5 |
| Hoda Tawfik | 5 |
| Stephan Jakober | 4 |
| Christian Schubert | 2 |
| Güunter Kast | 1 |
- Bolsa de valores
- Insiders
- Barbara von Frankenberg
- Conexiones Empresas
